Skip to main
  1. Stocks
  2. Merit Medical Systems
  3. Forecast
MMSI

MMSI Stock Forecast & Price Target

MMSI Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Merit Medical Systems is viewed favorably because its 3Q26 results showed broad-based organic growth of 8.9% and EPS of $1.12, both above consensus, while management raised full-year 2026 revenue guidance to $1.635B–$1.642B and EPS guidance to $4.33–$4.37. The outlook is supported by strength in the higher-growth Therapeutic and OEM businesses, improving Vascular Intervention trends, and reiterated WRAPSODY sales of about $7M in 2026, which together offset softer Foundational areas. Despite gross margin pressure from raw materials and freight, operating margin expanded to 21.3%, free cash flow was $53M in 3Q26, and leverage remained manageable at 1.5x, giving the company flexibility to fund growth and tuck-in acquisitions.

Bears say

Merit Medical Systems is facing a negative fundamental setup because the bear case assumes revenue growth of 5% or lower, with recent acquisitions contributing less and unsuccessful new product launches undermining operating leverage. That combination would likely drive further operating margin contraction and below-consensus earnings, leaving the business more exposed to disappointment in its core Cardiovascular segment, which supplies most revenue. Additional downside comes from risks of worse than expected margin performance, weaker free cash flow, and slower growth in China, possibly due to tenders.

MMSI has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Merit Medical Systems and is not a guaranteed prediction by Public.com or investment advice.

MMSI Analyst Forecast & Price Prediction

Get the latest MMSI stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MMSI

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Merit Medical Systems (MMSI) Forecast

Analysts have given MMSI a Buy based on their latest research and market trends.

According to 9 analysts, MMSI has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $104.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $104.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Merit Medical Systems (MMSI)


MMSI Analyst Forecast & Price Prediction

Get the latest MMSI stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in MMSI

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover MMSI stock data and trends